Martin is a registered medical practitioner who continues to practice in emergency medicine. He has over fifteen years experience in the medical devices field, both as a regulator and within the industry in Australia and internationally.

Martin was previously the head of the clinical section in medical devices at the Therapeutic Goods Administration (TGA) in Australia, a statutory body of the Australian Government that regulates the supply of therapeutic goods (medical devices, medicines, etc.) in Australia. His role included the provision of high level advice on clinical considerations in the regulation of medical devices; participation on the TGA's Medical Devices Expert Committee (MDEC) and Medical Device Incident Review Committee (MDIRC); the development of legislation and policy initiatives both nationally and internationally, including input into the workings of the Global Harmonisation Task Force (GHTF); participation as a member on a committee of Standards Australia; and the auditing of quality management systems to ISO 13485.

He has also held senior positions within multinational medical device companies, including COOK Medical and Covidien. In these positions, he provided high-level clinical advice on pre- and post-market safety, quality, performance, and marketing issues pertaining to the manufacture and supply of medical devices globally.

Martin founded Lifecycle Medical and is the company's Managing Director. He brings medical devices experience from both the regulator and the industry, and his expertise encompasses clinical and regulatory input into all aspects of medical device research and development, manufacturing, and commercialisation, including clinical trials, clinical evidence, and post-marketing issues; health technology assessment of medical devices for reimbursement; and quality management system auditing to ISO 13485 and clinical trial auditing to ICH GCP.

Martin has also successfully completed the Company Directors Course (CDC) through the Australian Institute of Company Directors (AICD) and has been a Director on a number of Boards. He is therefore also able to provide corporate advisory services to companies pursuing the commercialisation of medical devices.